Stroke trials in China
489 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in ChinaAn Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH
- Where
- Xi'an
- Age
- 10 years to 80 years
- People
- 30
- Run by
- Tang-Du Hospital
See details and how to joinNCT07528235 - Phase 4Not yet taking people in ChinaButylphthalide for Brain Edema After Endovascular Treatment
- Where
- Dongguan, Ganzhou, Guangzhou, Haikou, Heyuan, Qingyuan, Shaoguan
- Age
- 18 years and over
- People
- 100
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07528456 - No phaseTaking peopleCirculating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)
- Where
- Nanjing
- Age
- 18 years to 90 years
- People
- 300
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT04230785 - No phaseTaking peopleDifferent Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
- Where
- Nanjing
- Age
- 18 years and over
- People
- 5,000
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT05410457 - Phase 3Taking peopleEfficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
- Where
- Beijing
- Age
- 18 years and over
- People
- 850
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06658197 - Phase 3Taking peopleA Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
- Where
- Beijing, Daqing, Hengshui, Linfen, Linyi, Meihekou, Nanyang, Shenyang, Xianyang
- Age
- 18 years to 85 years
- People
- 1,112
- Run by
- Biocells (Beijing) Biotech Co.,Ltd
See details and how to joinNCT07520565 - Phase 2Taking peopleIntra-arterial Methylprednisolone After Endovascular Thrombectomy
- Where
- Xi'an
- Age
- 18 years to 80 years
- People
- 210
- Run by
- Tang-Du Hospital
See details and how to joinNCT07516522 - No phaseNot yet taking people in ChinaThe Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 6
- Run by
- yilong Wang
See details and how to joinNCT07514949 - No phaseTaking peopleA Sitting Tai Chi Programme for Chronic Stroke Survivors With Post-stroke Cognitive Impairment
- Where
- Kunming
- Age
- 18 years and over
- People
- 176
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07512739 - No phaseTaking peopleA Functional Near- Infrared Spectroscopy Study on the Brain Activation Characteristics of Stroke Patients During Mirror Movement
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 25
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07509944 - No phaseNot yet taking people in ChinaStudy on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke
- Where
- Chengdu
- Age
- 18 years and over
- People
- 1,508
- Run by
- West China Hospital
See details and how to joinNCT07507097 - Phase 3Taking peopleTenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
- Where
- Beijing
- Age
- 18 years and over
- People
- 330
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT06954155 - Phase 3Taking peopleAdvancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke
- Where
- Beijing, Hangzhou, Jiuquan, Jiyuan, Lingbao, Nantong, Shijiazhuang
- Age
- 18 years and over
- People
- 596
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07047014 - Phase 2Taking peopleRepeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)
- Where
- Shenyang
- Age
- 18 years to 80 years
- People
- 120
- Run by
- General Hospital of Shenyang Military Region
See details and how to joinNCT07375953 - Phase 2Taking peopleRepeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
- Where
- Shenyang
- Age
- 18 years to 80 years
- People
- 198
- Run by
- General Hospital of Shenyang Military Region
See details and how to joinNCT07375966 - No phaseEnrolling by invitationSmall Vessel Disease and Cerebral Infarct Healing InErvation Via Limb Distant Adaptation
- Where
- Hangzhou
- Age
- 50 years to 65 years
- People
- 80
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07503301 - No phaseNot yet taking people in ChinaEfficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke
- Where
- Changchun
- Age
- 18 years and over
- People
- 220
- Run by
- China-Japan Union Hospital
See details and how to joinNCT07483281 - No phaseNot yet taking people in ChinaRandomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion(REPAIR)
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 286
- Run by
- Feng Gao
See details and how to joinNCT07495969 - No phaseTaking peopleAcupuncture for Post-Stroke Dysphagia: A Clinical Study
- Where
- Tianjin
- Age
- 18 years to 80 years
- People
- 3,232
- Run by
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
See details and how to joinNCT07493902 - No phaseTaking peopleClinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia
- Where
- Hefei
- Age
- 18 years to 80 years
- People
- 40
- Run by
- The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07346378 - Phase 3Not yet taking people in ChinaEfficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
- Where
- Ankang, Anyang, Baise City, Changchun, Chengdu, Chongqing, Dali, Fuzhou, Guangyuan, Guilin, Guizhou, Huaibei, Jianyang, Jinan, Luoyang, Luzhou, Mianyang, Mudanjiang, Qiannan, Qingzhen, Qujing, Sanmenxia, Shangqiu, Suining, Tangshan, Wuhan, Xiangyang, Ya'an, Yichang, Zhengzhou, Zhoukou, Zhumadian, Zhuzhou, Zigong
- Age
- 18 years to 100 years
- People
- 488
- Run by
- Southwest Hospital, China
See details and how to joinNCT07469293 - No phaseTaking peopleSafety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.
- Where
- Chongqing
- Age
- 18 years to 85 years
- People
- 40
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06275516 - Phase 4Taking peopleTenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
- Where
- Beijing
- Age
- 18 years and over
- People
- 316
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT07203625 - No phaseTaking peopleEffective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
- Where
- Linyi, Qingdao
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT05578300 - Phase 3Not yet taking people in ChinaPrecision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
- Where
- Anshan, Benxi, Chaoyang, Dalian, Dandong, Fushun, Fuxin, Fuzhou, Huludao, Jinzhou, Liaoyang, Panjin, Shenyang, Tieling, Wafangdian, Yingkou
- Age
- 18 years and over
- People
- 864
- Run by
- First Hospital of China Medical University
See details and how to joinNCT07476898